New combo therapy aims to slow prostate cancer spread
NCT ID NCT06991556
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, JSB462, combined with standard therapy (abiraterone) in 150 men whose prostate cancer has spread but still responds to hormone treatment. The goal is to see if the combination lowers PSA levels more effectively and delays cancer growth. Participants will receive either the new combo or another standard treatment, and researchers will monitor safety and side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Advanced Urology Ins Daytona Beach
RECRUITINGDaytona Beach, Florida, 32114, United States
-
American Oncology Partners PA Center for Cancer and Blood Disorders
RECRUITINGBethesda, Maryland, 20817, United States
-
Associated Med Professionals of NY
RECRUITINGSyracuse, New York, 13210, United States
-
Associated Urological Specialists
RECRUITINGChicago Ridge, Illinois, 60415, United States
-
Carolina Urologic Research Center
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
Emory University School of Medicine-Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
-
Fred Hutch Cancer Research
RECRUITINGSeattle, Washington, 98109, United States
-
Mass General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Michigan Institute of Urology
RECRUITINGWest Bloomfield, Michigan, 48322, United States
-
MidLantic Urology
RECRUITINGBala-Cynwyd, Pennsylvania, 19004, United States
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10467, United States
-
Novartis Investigative Site
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Novartis Investigative Site
RECRUITINGClayton, Victoria, 3168, Australia
-
Novartis Investigative Site
RECRUITINGFortaleza, Ceará, 60140-025, Brazil
-
Novartis Investigative Site
RECRUITINGSão Paulo, São Paulo, 01221-020, Brazil
-
Novartis Investigative Site
RECRUITINGVancouver, British Columbia, V5Z 1M9, Canada
-
Novartis Investigative Site
RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
-
Novartis Investigative Site
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Novartis Investigative Site
RECRUITINGBeijing, Chaoyang, 100021, China
-
Novartis Investigative Site
RECRUITINGBeijing, 100034, China
-
Novartis Investigative Site
RECRUITINGBrno, 656 53, Czechia
-
Novartis Investigative Site
RECRUITINGOlomouc, 779 00, Czechia
-
Novartis Investigative Site
RECRUITINGPrague, 150 06, Czechia
-
Novartis Investigative Site
RECRUITINGNice, Alpes Maritimes, 06189, France
-
Novartis Investigative Site
RECRUITINGMarseille, 13273, France
-
Novartis Investigative Site
RECRUITINGQuint-Fonsegrives, 31130, France
-
Novartis Investigative Site
RECRUITINGSuresnes, 92150, France
-
Novartis Investigative Site
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40225, Germany
-
Novartis Investigative Site
RECRUITINGHamburg, 20246, Germany
-
Novartis Investigative Site
RECRUITINGLübeck, 23538, Germany
-
Novartis Investigative Site
RECRUITINGNürtingen, 72622, Germany
-
Novartis Investigative Site
RECRUITINGAsti, AT, 14100, Italy
-
Novartis Investigative Site
RECRUITINGPadova, PD, 35128, Italy
-
Novartis Investigative Site
RECRUITINGTrento, TN, 38122, Italy
-
Novartis Investigative Site
RECRUITINGOrbassano, TO, 10043, Italy
-
Novartis Investigative Site
RECRUITINGVerona, VR, 37134, Italy
-
Novartis Investigative Site
RECRUITINGZwolle, Overijssel, 8025 AB, Netherlands
-
Novartis Investigative Site
RECRUITINGDordrecht, South Holland, 3318 AT, Netherlands
-
Novartis Investigative Site
RECRUITINGHoofddorp, 2134 TM, Netherlands
-
Novartis Investigative Site
RECRUITINGSchiedam, 3118 JH, Netherlands
-
Novartis Investigative Site
RECRUITINGKielce, 25-640, Poland
-
Novartis Investigative Site
RECRUITINGOlsztyn, 10-288, Poland
-
Novartis Investigative Site
RECRUITINGOświęcim, 32-600, Poland
-
Novartis Investigative Site
RECRUITINGSkorzewo, 60-185, Poland
-
Novartis Investigative Site
RECRUITINGSingapore, 119074, Singapore
-
Novartis Investigative Site
RECRUITINGSingapore, 169608, Singapore
-
Novartis Investigative Site
RECRUITINGSingapore, S308433, Singapore
-
Novartis Investigative Site
RECRUITINGSeoul, 03080, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 06351, South Korea
-
Novartis Investigative Site
RECRUITINGSantander, Cantabria, 39008, Spain
-
Novartis Investigative Site
RECRUITINGBadajoz, Extremadura, 06080, Spain
-
Novartis Investigative Site
RECRUITINGLugo, Galicia, 27003, Spain
-
Novartis Investigative Site
RECRUITINGPamplona, Navarre, 31008, Spain
-
Novartis Investigative Site
RECRUITINGBarcelona, 08036, Spain
-
Novartis Investigative Site
RECRUITINGCórdoba, 14004, Spain
-
Novartis Investigative Site
RECRUITINGKaohsiung City, 83301, Taiwan
-
Novartis Investigative Site
RECRUITINGTainan, 704302, Taiwan
-
Perlmutter Cancer Centre
RECRUITINGNew York, New York, 10016, United States
-
Rocky Mountain Cancer Centers
RECRUITINGDenver, Colorado, 80218, United States
-
Saint Johns Cancer Institute
RECRUITINGSanta Monica, California, 90404, United States
-
Tennessee Oncology
RECRUITINGNashville, Tennessee, 37203, United States
-
University of California San Diego - Moores Cancer Center
RECRUITINGLa Jolla, California, 92093-0658, United States
-
Urology San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
Virginia Oncology Associates
RECRUITINGNorfolk, Virginia, 23502, United States
-
XCancer Omaha LLC
RECRUITINGOmaha, Nebraska, 68130, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06520, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Half the dose, same hope? trial tests cutting hormone therapy in prostate cancer
- Which prostate cancer drug is safer for the heart? new study aims to find out
- Exercise study aims to boost quality of life for men with metastatic prostate cancer
- New cocktail aims to stall spread of prostate cancer
- Prostate cancer Pill-Taking habits under the microscope
- New model predicts prostate cancer treatment response using PET scans